MedPath

Scaling-up Psychological Interventions With Syrian Refugees in Switzerland

Not Applicable
Completed
Conditions
Distress
Anxiety
Depression
Common Mental Health Problems
Trauma
PTSD
Functional Disabilities
Interventions
Behavioral: Problem Management Plus
Registration Number
NCT03830008
Lead Sponsor
University of Zurich
Brief Summary

The current refugee crisis across the Middle East and Europe has large effects on individual refugees' psychological well-being, as well as on the healthcare systems of countries hosting refugees. For example, in Switzerland patients sometimes have to wait up to 12 months for the specific psychological treatment due to a lack of specialists. To address this problem the WHO has developed Problem Management Plus (PM+), a brief (five sessions), low-intensity psychological intervention, delivered by paraprofessionals, that addresses common mental disorders in people in communities affected by adversity. The feasibility of PM+ has never been examined in Switzerland before, this is the aim of the current pilot study.

Detailed Description

Recent crises in the Middle East, most notably in Syria, have resulted in an unprecedented increase in the worldwide number of refugees and asylum seekers. Switzerland (CH) is strongly affected by this crisis too. Eight percent of asylum requests in 2016 were made by people from Syria (2015: 12 %). More than 7'000 asylum seekers from Syria entered CH over the last two years. Due to the ongoing war in this region, it is unlikely that this kind of migration and flight will stop. Notably, 50% of the refugee population are children and adolescents.

Refugees have typically been exposed to multiple stressors related to war and displacement including loss of family members, destruction of homes and livelihoods and human rights violations such as sexual violence or torture. They have often undertaken a risky and stressful flight leaving their homes for an unknown future. Accordingly, studies consistently show that refugees are at considerable risk of developing common mental disorders, including depression, anxiety, posttraumatic stress disorder (PTSD) and related somatic health symptoms. Recent WHO projections suggest that approximately 15-20% of Syrian refugees will develop some type of mental health problem and therefore represent an enormous public mental health challenge.

According to the UNHCR, 86% of all displaced persons remain in conflict or neighboring countries where appropriate health care is mostly not available. But also Western health systems are often unable to appropriately cover the needs of this particularly vulnerable population regarding prevention and treatment of mental health problems. As a response to this situation, the WHO developed the low-intensity Problem Management Plus (PM+) programs, a new generation of shorter, less expensive and trans-diagnostic (i.e., not specifically aimed at treating a certain mental disorder) programs to reduce common mental health symptoms and improve psychosocial functioning. PM+ is based on the WHO treatment guidelines for conditions related to stress. PM+ is a 5-sessions intervention aimed at reducing symptoms of depression, anxiety, PTSD, and related conditions, is delivered by trained non-specialized workers or lay people, and is available in individual and group delivery formats for both children and adults. It comprises evidence-based techniques of (a) problem solving, (b) stress management, (c) behavioral activation, and (d) accessing social support. PM+ has been successfully implemented in Kenya and Pakistan.

The STRENGTHS (Syrian REfuGees MeNTal HealTH Care Systems) study aims at evaluating the effectiveness and implementation of PM+ with Syrian refugees in different settings in low- and high-resource countries. The study consortium includes international experts in the domains of trauma and public mental health as well as representatives of WHO and UNHCR. The Zürich study site has been consigned to examine PM+ with adult refugees in an individual treatment setting in Switzerland. At the same time, similar studies in other countries will be undertaken. Despite the objective of these studies to implement and evaluate the effectiveness of PM+ in refugees, each research institution acts independently. Moreover, the other studies will be completed in different treatment settings - i.e., in children and adolescents (Lebanon), in groups (Turkey and Netherlands), and internet-delivered PM+ (Germany and Egypt).

To date, the feasibility of PM+ has not been investigated in a highly industrialized country, such as Switzerland.

In the present study, the investigators will evaluate the feasibility of PM+ in Syrian refugees in Switzerland.

This research entails single-blind randomized controlled trial.

The amendment was secured by December 2018. Trainers, assessors, supervisors and helpers are already identified, recruited an trained.

After the approval, the first participants will be identified, invited to screening and if they fulfill the criteria they will be invited to participate in the pilot study. The pilot study will end by the end of 2019. After the pilot study the results will be evaluated, analyzed and integrated in the planning of the definitive randomized controlled trial (RCT) (next study, not the part of current registration).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • Male and female Syrian refugees or asylum seekers who entered Switzerland after the beginning of Syrian Civil War in March 2011
  • ≥ 18 years of age
  • Arabic-speaking
  • Signed Informed Consent after being informed
  • Increased psychological distress (K10 > 15)
  • Reduced psychological functioning (WHODAS 2.0 > 16)
Exclusion Criteria
  • Inability to follow the procedures of the study
  • Previous enrolment into the current study
  • Previous or currently enrolment of a family member into the current study
  • Participants under tutelage
  • Acute or severe psychiatric (e.g. schizophrenia) or neurological illness (e.g. dementia)
  • Imminent suicide risk

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Problem Management PlusProblem Management PlusPM+ is a new, brief, psychological intervention program based on Cognitive Behaviour Therapy (CBT) techniques that are empirically supported and formally recommended by the WHO. The full protocol was developed by the WHO and the University of New South Wales, Australia. The manual involves the following empirically supported elements: problem solving plus stress management, behavioural activation, facing fears, and accessing social support. These elements have been recommended in recent WHO guidelines.
Primary Outcome Measures
NameTimeMethod
Verification procedure to the measurement in psychological distress after PM+ intervention or ETAUpost-assessment baseline (after PM+/ETAU)

measured by the Hopkins Symptom Checklist (HSCL-25)

Verification procedure to the measurement in psychological distress at baseline assessmentbaseline assessment (before PM+)

measured by the Hopkins Symptom Checklist (HSCL-25)

Verification procedure to the measurement in psychological distress 3 months after PM+ intervention or ETAU3-months follow-up (after PM+/ETAU)

measured by the Hopkins Symptom Checklist (HSCL-25)

Secondary Outcome Measures
NameTimeMethod
Feasibility of PM+ by feedbacks regarding the understanding of intervention and measurements instruments3-months follow-up (after PM+/ETAU)

Monitoring of wrong understanding or wrong translation (by number of patients and the scope of the feedback)

Verification procedure to the measurement of symptoms of posttraumatic stress disorder at baseline assessmentbaseline assessment (before PM+)

measured using the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (PCL-5)

Verification procedure to the measurement of functional disability at screeningscreening (before PM+)

assessed by the WHODAS 2.0 (WHO Disability Assessment Schedule 2.0)

Verification procedure to the measurement of functional disability 3 months after PM+ intervention or ETAU3-months follow-up (after PM+/ETAU)

assessed by the WHODAS 2.0 (WHO Disability Assessment Schedule 2.0)

Verification procedure to the measurement of symptoms of posttraumatic stress disorder after PM+ intervention or ETAUpost-assessment baseline (after PM+/ETAU)

measured using the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (PCL-5)

Verification procedure to the measurement of symptoms of posttraumatic stress disorder 3 months after PM+ intervention or ETAU3-months follow-up (after PM+/ETAU)

measured using the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (PCL-5)

Verification procedure to the measurement of functional disability after PM+ intervention or ETAUpost-assessment baseline (after PM+/ETAU)

assessed by the WHODAS 2.0 (WHO Disability Assessment Schedule 2.0)

Feasibility of PM+ by the number of dropouts3-months follow-up (after PM+/ETAU)

Monitoring of the dropouts by number of patients

Trial Locations

Locations (1)

University Hospital Zurich

🇨🇭

Zürich, ZH, Switzerland

© Copyright 2025. All Rights Reserved by MedPath